The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Open accessAbstract
Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This discrepancy may be attributed to nonpharmacological processes, such as nocebo effects, due to the commonality of symptoms.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [42]
In the citing paper
“Undue emphasis on discontinuation effects may increase the likelihood of real and debilitating symptoms, which arise (or are maintained) via processes distinct from pharmacological mechanisms (eg, nocebo effects).”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [42]
In the citing paper
“Similarly, there is evidence suggesting that negative expectations can contribute to a variety of side effects and adverse events in clinical trials and medical care (Amanzio et al., 2009; Barsky et al., 2002; Colloca and Finniss, 2012; Petersen et al., 2014).”
From Distinct neural representations of placebo and nocebo effects (2015) · cites this paper as Barsky et al., 2002
Citations
Cites
The Psychology of Physical Symptoms
Pennebaker, J. W. (1982) · Springer eBooks · doi:10.1007/978-1-4613-8196-9 · Cited by 1,789
BARSKY, A. J., & Borus, J. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00016 · Cited by 964
Self-citationDrug-related morbidity and mortality. A cost-of-illness model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.18.1949 · Cited by 942
The Importance of Placebo Effects in Pain Treatment and Research
Turner, J. A. (1994) · JAMA · doi:10.1001/jama.1994.03510440069036 · Cited by 871
The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly
Col, N. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390160093019 · Cited by 765
Drug-Related Hospital Admissions
Einarson, T. R. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700702 · Cited by 520
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W. J., Korff, M. V., Lin, E. H. B., Bush, T. M., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 519
Frequency and cost of serious adverse drug reactions in a department of general medicine
Moore, N. D., Lecointre, D., Noblet, C., & Mabille, M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00667.x · Cited by 322
Morphine Analgesic Tolerance: Its Situation Specificity Supports a Pavlovian Conditioning Model
Siegel, S. (1976) · Science · doi:10.1126/science.935870 · Cited by 318
Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness
de Craen, A. J. M., Roos, P., de Vries, A. L., & Kleijnen, J. (1996) · BMJ · doi:10.1136/bmj.313.7072.1624 · Cited by 313
Cited by
Sorted by citations
Items 201–300 of 783
The nocebo effect during oral challenge in subjects with adverse drug reactions.
Lombardi, C., Gargioni, S., Canonica, G. W., & Passalacqua, G. (2008) · PubMed · Cited by 40
Faasse, K., & Petrie, K. J. (2016) · Current Directions in Psychological Science · doi:10.1177/0963721416657316 · Cited by 41
Trigger warnings and resilience in college students: A preregistered replication and extension.
Bellet, B. W., Jones, P. J., Meyersburg, C. A., Brenneman, M. M., Morehead, K. E., & McNally, R. J. (2020) · Journal of Experimental Psychology Applied · doi:10.1037/xap0000270 · Cited by 40
Incidence and Nature of Antidepressant Discontinuation Symptoms
Kalfas, M., Tsapekos, D., Butler, M., McCutcheon, R. A., Pillinger, T., Strawbridge, R., Bhat, B. B., Haddad, P. M., Cowen, P. J., Howes, O. D., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1362 · Cited by 42
Development of the Drug Adherence Work-up (DRAW) tool
Doucette, W. R., Farris, K. B., Youland, K. M., Newland, B. A., Egerton, S. J., & Barnes, J. (2012) · Journal of the American Pharmacists Association · doi:10.1331/japha.2012.12001 · Cited by 39
Doering, B. K., Nestoriuc, Y., BARSKY, A. J., Glaesmer, H., Brähler, E., & Rief, W. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.10.010 · Cited by 39
Self-citationHeisig, S. R., Mora, M. C. S., von Blanckenburg, P., Rief, W., Witzel, I., Albert, U., & Nestoriuc, Y. (2016) · Psycho-Oncology · doi:10.1002/pon.4089 · Cited by 39
Mahoney, M. R., Sargent, D. J., O’Connell, M. J., Goldberg, R. M., Schaefer, P., & Buckner, J. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.0588 · Cited by 39
Ma, C., Panaccione, N., Nguyen, T. M., Guizzetti, L., Parker, C. E., Hussein, I. M., Casteele, N. V., Khanna, R., Dulai, P. S., Singh, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz087 · Cited by 38
Schultheiss, J. P. D., Brand, E. C., Lamers, E., van den Berg, W. C. M., van Schaik, F. D. M., Oldenburg, B., & Fidder, H. H. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15380 · Cited by 38
Polich, G. R., Iaccarino, M. A., Kaptchuk, T. J., Morales-Quezada, L., & ZAFONTE, R. D. (2019) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001290 · Cited by 39
Understanding and Preventing Health Concerns About Emerging Mobile Health Technologies
Materia, F. T., Faasse, K., & Smyth, J. M. (2020) · JMIR mhealth and uhealth · doi:10.2196/14375 · Cited by 42
Barrett, B. P., Rakel, D., Chewning, B. A., Marchand, L. R., Rabago, D., Brown, R., Scheder, J. C., Schmidt, R., Gern, J. E., Bone, K. M., et al. (2007) · EXPLORE · doi:10.1016/j.explore.2007.08.001 · Cited by 39
There’s More to Placebo-Related Improvement Than the Placebo Effect Alone
Andrade, C. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12f08124 · Cited by 37
Webster, R., Weinman, J. A., & Rubin, G. J. (2017) · Drug Safety · doi:10.1007/s40264-017-0542-1 · Cited by 37
Nocebo effects in health psychology
Faasse, K. (2019) · Australian Psychologist · doi:10.1111/ap.12392 · Cited by 42
Psychosocial Factors Affecting Parental Report of Symptoms in Children: A Systematic Review
Smith, L., Weinman, J. A., Yiend, J., & Rubin, G. J. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000767 · Cited by 41
Michnevich, T., Pan, Y., Hendi, A., Oechsle, K., Stein, A., & Nestoriuc, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-10089-2 · Cited by 37
Whitford, H. S., & Olver, I. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.06.026 · Cited by 34
A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions
Chaipichit, N., Krska, J., Pratipanawatr, T., Uchaipichat, V., & Jarernsiripornkul, N. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1653-6 · Cited by 36
Expectation-Focused Psychotherapy to Improve Clinical Outcomes
Doering, B. K., Glombiewski, J. A., & Rief, W. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.004 · Cited by 37
Pearson, A., & Pfeifer, G. (2020) · Psychological Reports · doi:10.1177/0033294120965461 · Cited by 38
Olver, I. N., Taylor, A., & Whitford, H. (2005) · Psycho-Oncology · doi:10.1002/pon.804 · Cited by 38
Medicine's inconvenient truth: the placebo and nocebo effect
Arnold, M. H., Finniss, D. G., & Kerridge, I. (2014) · Internal Medicine Journal · doi:10.1111/imj.12380 · Cited by 36
Webster, R., Weinman, J. A., & Rubin, G. J. (2017) · Health Expectations · doi:10.1111/hex.12584 · Cited by 35
Lasselin, J., Petrović, P., Olsson, M. J., Göranson, S. P., Lekander, M., Jensen, K. B., & Axelsson, J. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.008 · Cited by 36
Using Positive Attribute Framing to Attenuate Nocebo Side Effects: A Cybersickness Study
Mao, A., Barnes, K., Sharpe, L., Geers, A. L., Helfer, S. G., Faasse, K., & Colagiuri, B. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa115 · Cited by 35
An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review
Hariprasad, S. M., Gale, R. P., Weng, C. Y., Ebbers, H. C., Rezk, M. F., & Tadayoni, R. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00488-w · Cited by 35
Short-term side-effects of brain MR examination at 7 T: a single-centre experience
Cosottini, M., Frosini, D., Biagi, L., Pesaresi, I., Costagli, M., Tiberi, G., Symms, M. R., & Tosetti, M. (2014) · European Radiology · doi:10.1007/s00330-014-3177-y · Cited by 35
Power, M., & Hopayian, K. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2011.100271 · Cited by 35
Dömötör, Z., Doering, B. K., & Köteles, F. G. (2016) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12271 · Cited by 34
Tutter, A. (2006) · Journal of the American Psychoanalytic Association · doi:10.1177/00030651060540031401 · Cited by 34
Moon, J., Cohen Sedgh, R., & Jackevicius, C. A. (2021) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007480 · Cited by 33
Brain mechanisms underlying the placebo effect in neurological disorders.
Cavanna, A. E., Strigaro, G., & Monaco, F. (2007) · PubMed · Cited by 33
Stortenbeker, I. A., Houwen, J., Lucassen, P. L., Stappers, H. W., Assendelft, W. J., van Dulmen, S., Hartman, T. O., & Das, E. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.05.002 · Cited by 41
Does Googling lead to statin intolerance?
Khan, S. H., Holbrook, A. M., & Shah, B. R. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.085 · Cited by 33
Who responds to placebos? Considering the “placebo personality” via a transactional model
Darragh, M., Booth, R. J., & Consedine, N. S. (2014) · Psychology Health & Medicine · doi:10.1080/13548506.2014.936885 · Cited by 34
Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials
Zis, P., & Mitsikostas, D. D. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.029 · Cited by 32
The adverse event profile of pregabalin across different disorders: a meta-analysis
Zaccara, G., Perucca, P., & Gangemi, P. F. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1213-x · Cited by 32
Placebo and Nocebo Effects: An Introduction to Psychological and Biological Mechanisms
Kong, J., & Benedetti, F. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_1 · Cited by 34
Nestoriuc, Y., Pan, Y.-Q., Kinitz, T., Weik, E., & Shedden-Mora, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.587122 · Cited by 30
Bardana, E. J. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00081-4 · Cited by 32
Neurophysiologic Correlates of Side Effects in Normal Subjects Randomized to Venlafaxine or Placebo
Hunter, A. M., Leuchter, A. F., Morgan, M. L., Cook, I. A., Abrams, M., Siegman, B., DeBrota, D. J., & Potter, W. Z. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300652 · Cited by 33
Placebo and nocebo effects: from observation to harnessing and clinical application
Tu, Y., Zhang, L., & Kong, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02293-2 · Cited by 34
Zis, P., Shafiq, F., & Mitsikostas, D. D. (2016) · Seizure · doi:10.1016/j.seizure.2016.12.003 · Cited by 31
Chacon, M. R., Enrico, D. H., Burton, J., Waisberg, F., & Videla, V. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5617 · Cited by 32
Operant conditioning as a new mechanism of placebo effects
Bąbel, P. (2020) · European Journal of Pain · doi:10.1002/ejp.1544 · Cited by 31
Placebo: a brief updated review
Pardo-Cabello, A. J., Manzano‐Gamero, V., & Puche-Cañas, E. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02280-w · Cited by 32
Katz, A. J., Dusetzina, S. B., Farley, J. F., Ellis, A. R., Gaynes, B. N., Castillo, W. C., Stürmer, T., & Hansen, R. A. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2011.01020.x · Cited by 30
Bräscher, A., Kleinböhl, D., Hölzl, R., & Becker, S. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02163 · Cited by 32
The Influence of Expectation on Nondeceptive Placebo and Nocebo Effects
Wei, H., Zhou, L., Zhang, H., Chen, J., Lu, X., & Hu, L. (2018) · Pain Research and Management · doi:10.1155/2018/8459429 · Cited by 32
Fernandez, A., Kirsch, I., Noël, L., Rodondi, P., Kaptchuk, T. J., Suter, M. R., Décosterd, I., & Berna, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209851 · Cited by 28
When do the federal regulations allow placebo-controlled trials in children?
Miller, F. G., Wendler, D. S., & Wilfond, B. S. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.43 · Cited by 30
Is There a Connection Between Electrosensitivity and Electrosensibility? A Replication Study
Szemerszky, R., Gubányi, M., Árvai, D., Dömötör, Z., & Köteles, F. G. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-015-9477-z · Cited by 30
March, J. S., Kratochvil, C. J., Clarke, G. N., Beardslee, W. R., Derivan, A., Emslie, G. J., Green, E. P., Heiligenstein, J. H., Hinshaw, S. P., Hoagwood, K., et al. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000129606.83206.77 · Cited by 30
Parekh, N., Gahagan, B., Ward, L., & Ali, K. (2018) · Age and Ageing · doi:10.1093/ageing/afy142 · Cited by 29
Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination
Schäfer, I., Oltrogge, J. H., Nestoriuc, Y., Warren, C. V., Brassen, S., Blattner, M., Lühmann, D., Tinnermann, A., Scherer, M., & Büchel, C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4732 · Cited by 30
Zur Problematik von Akupunkturstudien am Beispiel der Methodik von gerac
Endres, H. G., Zenz, M. W., Schaub, C., Molsberger, A. F., Haake, M., Streitberger, K., Skipka, G., & Maier, C. (2004) · Der Schmerz · doi:10.1007/s00482-004-0345-z · Cited by 28
Mahmmod, S., Schultheiss, J. P. D., Bodegraven, A. A. V., Dijkstra, G. D. H., Gilissen, L. P. L., Hoentjen, F., Lutgens, M. W. M. D., Mahmmod, N., Jong, A. E. V. D. M., Smits, L. J. T., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa364 · Cited by 28
Distinct neural networks subserve placebo analgesia and nocebo hyperalgesia
Fu, J., Wu, S., Liu, C., Camilleri, J. A., Eickhoff, S. B., & Yu, R. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117833 · Cited by 30
The Nocebo Effect: A Review of Contemporary Experimental Research
Bagarić, B., Jokić‐Begić, N., & Jokić, C. S. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-10016-y · Cited by 29
Potential negative impact of informing patients about medication side effects: a systematic review
José, J., & AlHajri, L. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0716-7 · Cited by 30
Juanchich, M., & Sirota, M. (2019) · Applied Cognitive Psychology · doi:10.1002/acp.3623 · Cited by 28
The influence of psychological traits and prior experience on treatment expectations
Basedow, L. A., Fischer, A., Benson, S., Bingel, U., Brassen, S., Büchel, C., Engler, H., Mueller, E. M., Schedlowski, M., & Rief, W. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152431 · Cited by 32
Mitsikostas, D. D. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000313 · Cited by 27
Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature
Zis, P., & Mitsikostas, D. D. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.025 · Cited by 26
Kokoti, L., Drellia, K., Papadopoulos, D., & Mitsikostas, D. D. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09673-7 · Cited by 28
Gao, B., Sun, N., Yang, Y., Sun, Y., Chen, M., Chen, Z., & Wang, Z. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00435 · Cited by 27
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham‐Burley, S. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.10.013 · Cited by 26
Latent Inhibition Reduces Nocebo Nausea, Even Without Deception
Quinn, V. F., Livesey, E. J., & Colagiuri, B. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9867-8 · Cited by 26
Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review
Marshall, V. K., & Given, B. A. (2018) · Oncology nursing forum · doi:10.1188/18.onf.508-526 · Cited by 26
Sinyor, M., Cheung, C. P., Abraha, H. Y., Lanctôt, K. L., Saleem, M., Liu, C. S., Li, A., Juda, A., LEVITT, A. J., Cheung, A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.013 · Cited by 26
The use of the placebo effect in clinical medicine — ethical blunder or ethical imperative?
Biller‐Andorno, N. (2004) · Science and Engineering Ethics · doi:10.1007/s11948-004-0061-1 · Cited by 26
Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine
Dürsteler‐MacFarland, K. M., Stohler, R., Moldovanyi, A., Rey, S., Basdekis‐Jozsa, R., Gschwend, P., Eschmann, S., & Rehm, J. T. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.07.004 · Cited by 26
Why we need more research into the placebo response in psychiatry
Huneke, N. T. M., van der Wee, N. J. A., Garner, M. J., & Baldwin, D. S. (2020) · Psychological Medicine · doi:10.1017/s0033291720003633 · Cited by 26
The effects of ginger and its constituents in the prevention of metabolic syndrome: A review.
Salaramoli, S., Mehri, S., Yarmohammadi, F., Hashemy, S. I., & Hosseinzadeh, H. (2022) · PubMed · doi:10.22038/ijbms.2022.59627.13231 · Cited by 30
Promising influences of gingerols against metabolic syndrome: A mechanistic review
Alipour, A., Rahimi, V. B., & Askari, V. R. (2022) · BioFactors · doi:10.1002/biof.1892 · Cited by 25
Seitz, C. S., Bröcker, E., & Trautmann, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.020 · Cited by 25
Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros
Ain, K. B. (2015) · Endocrine · doi:10.1007/s12020-015-0668-9 · Cited by 25
Preventive Strategies for Borderline Personality Disorder in Adolescents
Chanen, A. M., & Thompson, K. N. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0029-y · Cited by 24
Nocebo response in Parkinson's disease: A systematic review and meta-analysis
Rato, M. L., Duarte, G. S., Nunes-Ferreira, A., Alves, M., Mainoli, B., Teodoro, T., Mestre, T., Costa, J. N., & Ferreira, J. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.04.015 · Cited by 24
SAMSON and the Nocebo Effect: Management of Statin Intolerance
Krishnamurthy, A., Bradley, C., Ascunce, R. R., & Kim, S. M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01729-x · Cited by 25
The Influence of Social Modeling, Gender, and Empathy on Treatment Side Effects
Faasse, K., Yeom, B. W., Parkes, B., Kearney, J., & Petrie, K. J. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kax025 · Cited by 26
The Power of Labeling in Nocebo Effects
Faasse, K., & Martin, L. R. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.016 · Cited by 25
Laferton, J. A. C., Vijapura, S., Baer, L., Clain, A. J., Cooper, A. R., Papakostas, G. I., Price, L. H., Carpenter, L. L., Tyrka, A. R., D, M. F. M., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00424 · Cited by 23
Adverse events of blood-pressure-lowering drugs: evidence of high incidence in a clinical setting
Gonçalves, C. B. C., Moreira, L. B., Gus, M., & Fuchs, F. D. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0352-y · Cited by 24
The Emotive Impact of Orthopedic Words
Vranceanu, A., Elbon, M., & Ring, D. (2011) · Journal of Hand Therapy · doi:10.1016/j.jht.2010.10.010 · Cited by 24
Stein, D. J., & Mayberg, H. S. (2005) · CNS Spectrums · doi:10.1017/s1092852900023117 · Cited by 23
de Wit, H. M., Groen, M. T., Rovers, M. M., & Tack, C. J. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12925 · Cited by 24
O’Connell, N., Nicholson, T. R., Blackman, G., Tavener, J., & David, A. S. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.04.004 · Cited by 23
Nocebo hyperalgesia can be induced by classical conditioning without involvement of expectancy
Bajcar, E. A., Adamczyk, W. M., Wiercioch‐Kuzianik, K., & Bąbel, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232108 · Cited by 19
Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?
D’Amico, F., Solitano, V., Peyrin‐Biroulet, L., & Danese, S. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1817374 · Cited by 23
Barker, J. M., & Faasse, K. (2023) · Internal Medicine Journal · doi:10.1111/imj.16220 · Cited by 23
Köteles, F. G. (2024) · Clinical Psychology Review · doi:10.1016/j.cpr.2024.102382 · Cited by 23
Determinants of nocebo effect during oral drug provocation tests
Bavbek, S., Aydın, Ö., Sözener, Z. Ç., & Yüksel, S. (2014) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2014.04.008 · Cited by 23
Understanding the placebo effect from an evolutionary perspective
Trimmer, P. C., Marshall, J. A. R., Fromhage, L., McNamara, J., & Houston, A. (2013) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2012.07.004 · Cited by 26
Symptom complaints of patients prescribed either oral methadone or injectable heroin
Dürsteler‐MacFarland, K. M., Fischer, D. A., Mueller, S. E., Schmid, O., Moldovanyi, A., & Wiesbeck, G. A. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.01.008 · Cited by 23
Quidde, J., Pan, Y., Salm, M., Hendi, A., Nilsson, S., Oechsle, K., Stein, A., & Nestoriuc, Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-4814-7 · Cited by 23
Psychosomatic concepts in chronic pain
Rashbaum, I. G., & Sarno, J. E. (2003) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2003.50144 · Cited by 23
Szemerszky, R., Dömötör, Z., Berkes, T., & Köteles, F. G. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-015-9511-1 · Cited by 24
Metadata
- Authors
- Barsky, A. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Barsky, Arthur J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-02-06
- Volume
- 287
- Issue
- 5
- Pages
- 622
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2030711540
- Cited by
- 784
- References
- 69
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 54 · 2021: 49 · 2020: 47 · 2019: 53 · 2018: 45 · 2017: 42 · 2016: 39 · 2015: 33 · 2014: 31 · 2013: 27 · 2012: 31
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- green
- dash.harvard.edu
- Licence
- cc-by
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- nocebo effect, adverse drug reactions, placebo effect, patient expectations, conditioning, anxiety, depression, somatization, patient-physician communication, risk factors
- MeSH terms
- Attitude to Health, Drug Therapy, Humans, Negativism, Placebos, Risk Factors, Effect Modifier, Epidemiologic, Placebo Effect, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review